Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy-Reference-Cited by-同舟云学术

Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy

Published:1991-11 Issue:11 Volume:68 Page:1203-1210
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Feldman Arthur M.,Baughman Kenneth L.,Lee William K.,Gottlieb Sheldon H.,Weiss James L.,Becker Lewis C.,Strobeck John E.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Epidemiology of congestive heart failure;Smith;Am J Cardiol,1985

2. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy;Franciosa;Am J Cardiol,1983

3. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS);N Engl J Med,1987

4. Do positive inotropic agents adversely affect the survival of patients with chronic congestive heart failure?;Cody;J Am Coll Cardiol,1988

5. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxy benzoyl)-1-piperazinyl]-2(1HO-quinolinone (OPC-8212) a novel positive inotropic drug in various animals;Yamashita;Arzneimittelforschung,1984

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal Weighted Wilcoxon–Mann–Whitney Test for Prioritized Outcomes;New Frontiers of Biostatistics and Bioinformatics;2018

2. Insights from Second-Line Treatments for Idiopathic Dilated Cardiomyopathy;Journal of Cardiovascular Development and Disease;2017-08-23

3. Vesnarinone;Meyler's Side Effects of Drugs;2016

4. Phosphodiesterase-III inhibitors amrinone and milrinone on epilepsy and cardiovascular activities;North American Journal of Medical Sciences;2012

5. In silico risk assessment for drug-induction of cardiac arrhythmia;Progress in Biophysics and Molecular Biology;2008-09